loading

You are welcome to send your RFP, feasibility questionnaire or other request at info@mt.clinic

    View Our Case Studies

    The network of clinical research sites, “Medical Technologies”, is a proven partner in clinical trials in volunteers and patients.

    Our team has a database of healthy volunteers of 7, 000 people. In clinical studies where healthy volunteers are required, our average recruitment rate is 100 volunteers per week, so our usual screening period in bioequivalence and phase I studies in healthy volunteers is 1-2 days.

    The team of Medical Technologies has a special team of employees whose responsibility is subjects’ recruitment in clinical trials through a network of referring doctors.

    The success of our patient recruitment is guaranteed due to our long-standing and well-established relationship with a network of referring doctors and sites.

    Our network is constantly expanding, which allows the network of the Medical Technologies sites to expand the list of therapeutic areas we work in.

    We work in the following areas:

    • Therapy
    • Pediatrics
    • Oncology
    • Gynecology
    • Infectious diseases
    • Gastroenterology
    • Dermatovenereology
    • Cardiology
    • Neurology
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Endocrinology
    • Surgery
    • Neurosurgery
    • Ophthalmology
    • Psychiatry
    • Narcology

    Based on specific inclusion / non-inclusion criteria, we provide our clients with an exact assessment of the patient recruitment rate during a feasibility stage.

    Our centers have repeatedly become top enrollers in clinical trials.

    Global top enroller

    • Worldwide top enrolling site in a clinical study in NSCLC

    Top enroller in Russian Federation

    • Russia’s top enrolling site in a clinical study in solid tumors
    • Russia’st op enrolling site in a clinical study in osteoarthritis
    • Russia’s top enrolling site in a clinical study in asthma
    • Russia’s second top enrolling site in a clinical study in NSCLC
    • Russia’s second top enrolling site in a clinical study in erectile dysfunction